Cajanin has potential hypolipidemic effects,possibly via up-regulating the ABCA1 protein expression,subsequently resulting in increased macrophage cholesterol efflux and RCT, it can significantly improve basal glucose uptake in HepG2 cells, its improving effect is concentration dependent, it exhibits effects stronger than that of rosiglitazone, which has been used as an antidiabetic drug.

YK-2-69 is a highly selective DYRK2 inhibitor with anti-prostate cancer effects.

2,6-二氯苯甲酸甲酯是一种用于蛋白质组学研究的生化化合物。